Abstract

A number of key developments have led to the routine microsequence analysis (low nanomole to subnanomole range) of peptides and proteins in a number of laboratories. In spinning cup microsequence analysis, the developments were improved instrument design and performance (1–4), better methods for solvent and reagent purification (2, 5), automated conversion of amino acid anilinothiozolinone to phenylthiohydantoin (PTH) derivatives (6), high sensitivity separation and quantitation of PTH derivatives by reverse-phase HPLC (2, 7–9), and retention of µg amounts of proteins and peptides in the spinning cup with polybrene (2, 10). The ability to perform routine microsequence analysis on µg amounts of peptides and proteins has led to structural studies on relative rare substances which possess important biological properties. In our laboratory we have used this methodology to obtain structural information on human leukocyte and fibroblast interferons (11–15) and on bovine adrenal opioid peptides (16–18). Over the past two years these studies have led us to consider another critical aspect of microsequence analysis, namely the compatibility of sample preparation with microsequence analysis.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.